Scott VanEpps — Latest News — The Max Harry Weil Institute for Critical Care Research and Innovation

Frankel Innovation Initiative awards Weil Institute investigators $250,000 to identify sepsis-causing bacteria faster and more accurately than gold-standard methods

A research team from the Weil Institute and Michigan Medicine received $250,000 to support work on a new tool that could revolutionize pathogen detection in patients with sepsis.

SepsisKate MurphyJanuary 13, 2023Sepsis and Multi-Organ Failure, Award Announcement, Scott VanEpps

(U-M Engineering) Weil Institute Associate Director and team develop coating that kills the COVID virus and other germs in minutes

(Source: Michigan Engineering) Weil Institute Associate Director Scott VanEpps, MD, PhD, and Weil Institute member Anish Tuteja, PhD are part of a team of immunologists and engineers developing a durable coating that can quickly kill bacteria and viruses. The coating proved deadly to SARS-CoV-2 , E. coli, MRSA and a variety of other pathogens in a recent study.

Kate MurphyAugust 29, 2022Sepsis and Multi-Organ Failure, engineering, immunology, Scott VanEpps, anish tuteja

Weil Institute associate director & team awarded grant to develop treatment strategy for central-line associated bloodstream infections (CLABSIs)

Treating CLABSIs frequently involves removing and replacing the central line, but a new strategy could mitigate the need for this risky process.

“High Risk, High Reward” work celebrated for MCIRCC Associate Director Scott VanEpps

MCIRCC Associate Director Scott VanEpps, M.D., Ph.D., FACEP has been named a Taubman Emerging Scholar effective September 1, 2019. The grant is given to support early-career physician-scientists at the assistant professor level.

SepsismukatelyAugust 12, 2019Associate Director, Scott VanEpps

Understanding White Blood Cells’ Defense Mechanisms Could Lead to Better Treatments

A laboratory-created microscopic network of fibers helped researchers understand how white blood cells capture and even kill bacteria, offering insight into the effectiveness of antibiotics in the future.

SepsismukatelyFebruary 1, 2019Antibiotics, Bacteria, Scott VanEpps

Game-changing Study Aims to Identify Pneumonia Pathogens Faster with Breakthrough Technologies

Pneumonia has been around for centuries and remains a major cause of morbidity, mortality, and healthcare expense today.

The most commonly used method for identifying respiratory pathogens in pneumonia - bacterial culture - was first developed in the 1880s. Though there have been many breakthroughs in our treatment of pneumonia - such as antibiotics and mechanical ventilation - our clinical identification of respiratory pathogens still relies on the time-consuming culture-based techniques.